114 related articles for article (PubMed ID: 9351002)
1. HIV-1 capsid mutants inhibit the replication of wild-type virus at both early and late infection phases.
Furuta RA; Shimano R; Ogasawara T; Inubushi R; Amano K; Akari H; Hatanaka M; Kawamura M; Adachi A
FEBS Lett; 1997 Sep; 415(2):231-4. PubMed ID: 9351002
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV replication by capsid mutant C6b.
Shimano R; Iida S; Fukumori T; Yamamoto Y; Kawamura M; Furuta RA; Adachi A
Biochem Biophys Res Commun; 1998 Jan; 242(2):313-6. PubMed ID: 9446791
[TBL] [Abstract][Full Text] [Related]
3. Early function of HIV-1 Gag proteins is cell-dependent.
Kawamura M; Shimano R; Inubushi R; Akari H; Adachi A
Biochem Biophys Res Commun; 1998 Jul; 248(3):899-903. PubMed ID: 9704024
[TBL] [Abstract][Full Text] [Related]
4. The role of nucleocapsid of HIV-1 in virus assembly.
Dawson L; Yu XF
Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
[TBL] [Abstract][Full Text] [Related]
5. Cell-dependent replication potentials of HIV-1 gag mutants.
Adachi A; Tamaki M; Shimano R; Inubushi R; Naito T; Yoshida K; Oshima Y; Kawamura M; Koyama AH
Microbes Infect; 1999 Jul; 1(9):671-6. PubMed ID: 10611744
[TBL] [Abstract][Full Text] [Related]
6. Suppression of HIV-2 replication by HIV-1 gag mutants.
Shimano R; Inubushi R; Fukumori T; Tamaki M; Oshima Y; Kawamura M; Adachi A
Biochem Biophys Res Commun; 1998 Jul; 248(2):418-21. PubMed ID: 9675152
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of Gag precursor is required for early replication phase of HIV-1.
Kawamura M; Shimano R; Inubushi R; Amano K; Ogasawara T; Akari H; Adachi A
FEBS Lett; 1997 Sep; 415(2):227-30. PubMed ID: 9351001
[TBL] [Abstract][Full Text] [Related]
8. Cell-dependent gag mutants of HIV-1 are crucially defective at the stage of uncoating/reverse transcription in non-permissive cells.
Koh K; Miyaura M; Yoshida A; Sakurai A; Fujita M; Adachi A
Microbes Infect; 2000 Oct; 2(12):1419-23. PubMed ID: 11099927
[TBL] [Abstract][Full Text] [Related]
9. Functional domain mapping of HIV-1 Gag proteins.
Kawamura M; Shimano R; Inubushi R; Amano K; Ogasawara T; Akari H; Adachi A
Biochem Biophys Res Commun; 1997 Dec; 241(2):317-20. PubMed ID: 9425269
[TBL] [Abstract][Full Text] [Related]
10. The potential of various HIV-1 mutants to inhibit the replication of wild-type virus.
Inubushi R; Shimano R; Oshima Y; Adachi A
Biochem Biophys Res Commun; 1998 Jun; 247(2):349-52. PubMed ID: 9642129
[TBL] [Abstract][Full Text] [Related]
11. Host cell-dependent replication of HIV-1 gag MA, CA, and NC mutants are independent of the functions of Vif and Vpu.
Shimano R; Inubushi R; Adachi A
Int J Mol Med; 1999 Jan; 3(1):91-4. PubMed ID: 9864392
[TBL] [Abstract][Full Text] [Related]
12. Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination.
Nikolaitchik O; Rhodes TD; Ott D; Hu WS
J Virol; 2006 May; 80(10):4691-7. PubMed ID: 16641262
[TBL] [Abstract][Full Text] [Related]
13. Cyclophilin A-independent replication of a human immunodeficiency virus type 1 isolate carrying a small portion of the simian immunodeficiency virus SIV(MAC) gag capsid region.
Fujita M; Yoshida A; Miyaura M; Sakurai A; Akari H; Koyama AH; Adachi A
J Virol; 2001 Nov; 75(21):10527-31. PubMed ID: 11581426
[TBL] [Abstract][Full Text] [Related]
14. Effect of mutations in NC7 on endogenous reverse transcription in HIV-1.
Hsu M; Cherry E; Quan Y; Richard N; Kleiman L; Wainberg MA
Leukemia; 1999 Apr; 13 Suppl 1():S113-5. PubMed ID: 10232383
[No Abstract] [Full Text] [Related]
15. Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication.
Tanchou V; Decimo D; Péchoux C; Lener D; Rogemond V; Berthoux L; Ottmann M; Darlix JL
J Virol; 1998 May; 72(5):4442-7. PubMed ID: 9557738
[TBL] [Abstract][Full Text] [Related]
16. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
[TBL] [Abstract][Full Text] [Related]
17. 1H NMR structure and biological studies of the His23-->Cys mutant nucleocapsid protein of HIV-1 indicate that the conformation of the first zinc finger is critical for virus infectivity.
Déméné H; Dong CZ; Ottmann M; Rouyez MC; Jullian N; Morellet N; Mely Y; Darlix JL; Fournié-Zaluski MC; Saragosti S
Biochemistry; 1994 Oct; 33(39):11707-16. PubMed ID: 7918387
[TBL] [Abstract][Full Text] [Related]
18. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
[TBL] [Abstract][Full Text] [Related]
19. Suppression of HIV replication by dominant negative mutants of HIV-1 (review).
Inubushi R; Shimano R; Oshima Y; Yoshida K; Kawamura M; Adachi A
Int J Mol Med; 1998 Sep; 2(3):325-30. PubMed ID: 9855705
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of two zinc finger motifs in HIV type 1 nucleocapsid proteins: effects on proteolytic processing of Gag precursors and particle formation.
Mizuno A; Ido E; Goto T; Kuwata T; Nakai M; Hayami M
AIDS Res Hum Retroviruses; 1996 Jun; 12(9):793-800. PubMed ID: 8738431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
